. CGP Centre of Genomics and Policy CGP Centre of Genomics and Policy

CPG Centre of Genomics and policy

Completed Research Projects

  • A HAPLOTYPE MAP OF THE HUMAN GENOME-BIOMEDICAL TOOL FOR GENETIC RESEARCH IN CANADA
  • A PROSPECTIVE STUDY TO IDENTIFY AND VALIDATE BIOMARKERS OF THERAPEUTIC RESISTANCE IN COLORECTAL METASTIC CANCER (Q-CROC)
  • A RESEARCH AND KNOWLEDGE NETWORK ON GENETIC HEALTH SERVICES AND POLICY: BUILDING ON THE APOGEE-NET AND CANGENETEST EXPERIENCES
  • A REVIEW OF APPROACHES CONSIDERING SOCIAL, ETHICAL, AND LEGAL ISSUES IN HEALTH TECHNOLOGY ASSESSMENT
  • A SYST-OMICS APPROACH TO ENSURING FOOD SAFETY AND REDUCING THE ECONOMIC BURDEN OF SALMONELLOSIS
  • ACCESS TO HEALTH INSURANCE IN THE CONTEXT OF PERSONALIZED MEDICINE
  • AN ETHICAL AND LEGAL FRAMEWORK FOR THE CANADIAN BREAST CANCER ALLIANCE “NATIONAL RETROSPECTIVE TISSUE MICROARRAY RESOURCE FOR BREAST CANCER”
  • ANTICIPATORY GOVERNANCE OF UNCERTAINTY AND FUTURE-IN-THE-PRESENT: MAPPING THE
  • APPLIED METAGENOMICS OF THE WATERSHED MICROBIOME
  • BIOBANK STANDARDISATION AND HARMONISATION FOR RESEARCH EXCELLENCE IN THE EUROPEAN UNION (BIOSHARE-EU)
  • BUILDING A GOVERNANCE TOOLKIT FOR CANADIAN HEALTHY INFANT LONGITUDINAL DEVELOPMENT (CHILD)
  • CANADA RESEARCH CHAIR IN LAW AND MEDICINE
  • CANADIAN MOLECULAR CYTOGENETICS PLATFORM
  • CANADIAN OPEN NEUROSCIENCE PLATFORM (CONP) – ETHICS AND GOVERNANCE COMMITTEE; SCHOLARSHIP SUPERVISION
  • CANADIAN PARTNERSHIP FOR TOMORROW PROJECT (CPTP)
  • CANADIAN PHARMACOGENOMICS NETWORK FOR DRUG SAFETY (CPNDS)
  • CARENET-SCN PARTNERSHIP: A FOCUS ON CLINICAL TRANSLATION OF STEM CELLS FOR CARDIOVASCULAR REGENERATION
  • CARTAGENE
  • CATALYZING UMBILICAL CORD BLOOD RESEARCH IN CANADA
  • CE IN BIOMARKER-DRIVEN CLINICAL RESEARCH FOR PERSONALIZED MEDICINE IN CANCER (EXACTIS)
  • CELL THERAPY FOR MUSCULAR DISEASE
  • CELL-BASED REGENERATIVE MEDICINE: NEW CHALLENGES FOR EU LEGISLATION AND GOVERNANCE (EUCELLEX)
  • CENTRE FOR COMMERCIALIZATION OF REGENERATIVE MEDICINE ("CCRM") ETHICS AND POLICY UNIT
  • CHIMERA AND HYBRID IN COMPARATIVE EUROPEAN AND INTERNATIONAL RESEARCH - SCIENTIFICAL, ETHICAL, PHILOSOPHICAL, AND LEGAL ASPECTS
  • CIHR EMERGING TEAM IN GENOMICS SCREENING
  • CIHR TEAM IN COMMUNITY GENETICS (ECOGENE-21)
  • CIHR TEAM OF PREDICTION AND COMMUNICATION OF FAMILIAL RISKS OF BREAST CANCER (INHERIT)
  • COMMUNICATION OF HEREDITARY BREAST CANCER RISK INFORMATION WITH FAMILIES: ETHICAL AND LEGAL FRAMEWORK
  • CONSENT PROTOCOLS FOR UCB DONATION AND BANKING PHASE 1
  • CULTURED EPITHELIAL AUTOGRAFTS FOR THE TREATMENT OF CORNEAL LIMBAL STEM CELL DEFICIENCIES
  • DESIGN AND EVALUATION OF ELECTRONIC CONSENT AND GOVERNANCE PROCESSES FOR CLINICAL RESEARCH
  • DEVELOPMENT OF A LEGAL DATABASE IN THE GLOBAL ETHICS OBSERVATORY
  • E-BROKERING: INCREASED KNOWLEDGE BROKERING OF HEALTH RESEARCH INFORMATION OVER THE WEB - WORKSHOP
  • EMERGING TEAM IN DEVELOPMENT OF STRATEGIES FOR UPTAKE AND ANALYSIS OF NANOSEQUENCING-DERIVED DATA SETS AND LINKING TO DISEASE
  • ENHANCED CARE FOR RARE GENETIC DISEASES IN CANADA
  • EPIGENOME-WISE: ETHICAL, LEGAL AND SOCIETAL ISSUES OF NEW ASSAYS FOR DNA-METHYLATION IN CANCER DIAGNOSTICS AND SCREENING
  • ETHICAL EVALUATION OF GENOMIC RESEARCH
  • EUROPEAN NETWORK FOR GENETIC AND GENOMIC EPIDEMIOLOGY (ENGAGE)
  • FINDING OF RARE DISEASE GENES IN CANADA (FORGE)
  • FRAMEWORK FOR DECISION-MAKING FOR RARE DISEASES
  • FROM BANKING TO INTERNATIONAL GOVERNANCE: FOSTERING INNOVATION IN STEM CELL
  • FROM THE LAB TO THE CLINIC: ELS ISSUES IN CANCER STEM CELL RESEARCH
  • GE3LS NETWORK IN GENOMICS AND PERSONALIZED HEALTH
  • GENETIC COUNSELLING IN QUEBEC FOR PRENATAL TESTING FOR INTERSEX CONDITIONS
  • GENETIC INFORMATION AND LIFE INSURANCE UNDERWRITING
  • GENETICS OF TYPE 2 DIABETES
  • GENOMIC TOOLS FOR DIAGNOSIS AND EVALUATION OF MENTAL RETARDATION
  • GENOMICS AND PROTEOMICS PLATFORMS FOR VACCINES AND IMMUNE THERAPEUTICS DISCOVERY AND DEVELOPMENT
  • GENOMICS AND PUBLIC HEALTH: BUILDING PUBLIC “GOODS”?
  • GRAPH-INT: GENOME-BASED RESEARCH AND POPULATION HEALTH INTERNATIONAL NETWORK - SECRETERIAT
  • HARMONIZING PRIVACY LAWS TO ENABLE INTERNATIONAL BIOBANK RESEARCH
  • HEALTHY BRAINS FOR HEALTHY LIVES OPEN SCIENCE POLICY KNOWLEDGE MOBILIZATION
  • HUMAN POPULATION GENETICS AND PUBLIC HEALTH: MULTIDISCIPLINARY ANALYSIS AND COMPARISON OF INTERNATIONAL NORMS AND PRACTICES
  • INFORMING EVIDENCE-BASED POLICY FOR EXPANDED NEWBORN SCREENING
  • INNOVATIVE CHEMOGENOMIC TOOLS TO IMPROVE OUTCOME IN ACUTE MYELOID LEUKEMIA
  • INTEGRATED RESEARCH NETWORK IN PERINATALOGY OF QUEBEC AND EASTERN ONTARIO (IRNPQ)
  • INTEGRATIVE EPIGENOMIC DATA COODINATION CENTRE (EDCC) AT MCGILL
  • INTEGRATIVE EPIGENOMIC DATA COORDINATION CENTRE (EDCC) AT MCGILL
  • INTERDISCIPLINARY HEALTH RESEARCH INTERNATIONAL TEAM ON BREAST CANCER SUSCEPTIBILITY (INHERIT BRCA)
  • INTERNATIONAL CANCER GENOME CONSORTIUM / DATA ACCESS COMPLIANCE OFFICE (DACO)
  • INTERNATIONAL CANCER GENOME CONSORTIUM/DATA ACCESS COMPLIANCE OFFICE
  • INTERNATIONAL INSTITUTE OF BIOMEDICAL ETHICS RESEARCH (IIREB)
  • INTERNATIONAL STEM CELL FORUM ETHICS WORKING PARTY (EWP)
  • INTESTINAL EPITHELIAL CELLS : GENE IDENTIFICATION AND NEW THERAPEUTIC APPROACHES
  • ITALY/QUEBEC PARTNERSHIP
  • L’ENCADREMENT JURIDIQUE DES TESTS D’ADN DANS LE CONTEXTE DU PROCESSUS DE PARRAINAGE DES MEMBRES DE LA FAMILLE DES IMMIGRANTS CANADIENS
  • LE DÉVELOPPEMENT D’UNE THÉRAPIE GÉNIQUE EFFICACE ET SÉCURITAIRE POUR L’ÉPIDERMOLYSE BULLEUSE RECESSIVE DYSTROPHIQUE ET JONCTIONNELLE
  • LE SÉQUENÇAGE DU GÉNOME ENTIER : UN « BULLETIN » GÉNÉTIQUE POUR CHAQUE ENFANT?
  • LEGAL FOUNDATIONS FOR A NATIONAL DISEASE CONTROL AND SURVEILLANCE AGENCY IN CANADA
  • MAKING CONNECTIONS IV – BIOBANKS: PATHWAYS TO TRANSLATION?
  • MAPPING THE LANGUAGE OF RESEARCH-BIOBANKS AND HEALTH REGISTRIES: FROM TRADITIONAL BIOBANKING TO RESEARCH BIOBANKING
  • MATERIAL TRANSFER AGREEMENTS (MTA’S)
  • MATERNAL INFANT CHILD & YOUTH RESEARCH NETWORK (MICYRN) PROMOTING HEALTH RESEARCH INVOLVING CHILDREN AND ADOLESCENTS
  • MATERNAL-INFANT RESEARCH ON ENVIRONMENTAL CHEMICALS: A NATIONAL PROFILE OF IN UTERO AND LACTATIONAL EXPOSURE (MIREC)
  • MATERNAL-INFANT RESEARCH ON OXIDATIVE STRESS (MIROS)
  • MODELS OF ETHICAL DECISION-MAKING IN BIOSCIENCE FIRMS
  • MULTIDIMENSIONAL EPIGENOMICS MAPPING CENTRE (EMC) AT MCGILL
  • NAC BIO
  • NANOMEDICINE: WHITHER POLICY AND REGULATION
  • NEXT GENERATION PREDICTIVE SIGNATURES FOR BREAST CANCER
  • OPEN SCIENCE AND THIRD-COUNTRY PERSONAL DATA TRANSFERS: “OPEN” UNLIMITED?
  • OPTIMISATION DES APPROCHES THÉRAPEUTIQUES EN SOINS PERSONNALISÉS DE PREMIÈRE LIGNE (OPTI-THERA)
  • OPTIMIZING PUBLIC CORD BANKING AND RESEARCH IN CANADA PHASE 2
  • P3G - PUBLIC POPULATION PROJECT IN GENOMICS
  • PERSONALIZED RISK STRATIFICATION FOR THE PREVENTION AND EARLY DETECTION OF BREAST CANCER (PERSPECTIVE)
  • PHARMACOGENOMICS
  • PHARMACOGENOMICS OF DRUG EFFICACY AND TOXICITY IN THE TREATMENT OF CARDIOVASCULAR DISEASE
  • PHARMACOGENOMICS WITH CHILDREN: TOWARDS A HEALTHIER FUTURE
  • PISTES DE RÉFORMES LÉGISLATIVES EN MATIÈRE DE PARRAINAGE FAMILIAL: UN CONSENSUS À ÉTABLIR SUR LES TESTS D’ADN DANS LES DOSSIERS D’IMMIGRATION
  • PREDISPOSITION, PREDICTION ET PREVENTION DU CANCER DU SEIN (PREVENTION)
  • PROJECT ARCHI (PILOT STUDY OF “PRECINOMICS”
  • PROTECTING PRIVACY IN CLOUD-BASED GENOMICS RESEARCH
  • PROTECTING PRIVACY IN THE POSTGENOMIC ERA : ENSURING RESPONSIBLE DATA GOVERNANCE BY DIRECT-TO-CONSUMER COMPANIES ENGAGING WITH EPIGENETICS, MICROBIOMICS AND INTEGRATIVE MULTI-OMICS
  • PUBLIC HEALTH CHALLENGED BY ZOONOSIS: ROLES AND POWERS OF THE STATE
  • QUEBEC TRAINING NETWORK IN PERINATAL RESEARCH (QTNPR)
  • RADICAL - RARE DISEASE CONSORTIUM FOR AUTOSOMAL LOCI
  • RECONCILING LAW AND ETHICS WITH OPEN SCIENCE IN BIOTECHNOLOGY RESEARCH
  • REFORMING CANADIAN STEM CELL POLICY: MOVING BEYOND THE ASSISTED HUMAN REPRODUCTION ACT (AHRA)
  • REGENERATIVE CELL THERAPY NETWORK (RCTN)
  • REGENERATIVE MEDICINE: ETHICAL, ENVIRONMENTAL, ECONOMIC, LEGAL AND SOCIAL ISSUES NETWORK (RMETHNET)
  • REGULATION OF BIOBANKS: BANKING WITHOUT CHECKS OR INSURED DEPOSITS
  • RESEARCH PROGRAM TO SUPPORT HEALTH POLITICS IN GENETICS, CONCERNED WITH QUALITY, EFFICIENCY AND SOCIAL WELFARE (APOGEE-NET)
  • RÉSEAU DE MÉDECINE GÉNÉTIQUE APPLIQUÉE (RMGA) INFRASTRUCTURE
  • RÉSEAU EN SOINS DE SANTÉ PERSONNALISÉS-Q-CROC
  • RETURNING RESEARCH RESULTS OF PEDIATRIC GENOMIC RESEARCH TO PARTICIPANTS
  • RISK STRATIFICATION FOR PREVENTION AND EARLY DETECTION OF BREAST CANCER: DEVELOPMENT AND IMPLEMENTATION OF COMMUNICATION TOOLS
  • SIMPLE MICROFLUID SYSTEM FOR RAPID AND ROBUST IDENTIFICATION OF PATHOGENS BY REAL-TIME PCR AT POINT-OF-CARE
  • SINO-QUÉBEC PERINATAL INITIATIVE IN RESEARCH AND INFORMATION TECHNOLOGY (SPIRIT)
  • STEM CELL NETWORK (NETWORK CENTRE OF EXCELLENCE)
  • STEM CELL-BASED GENE THERAPY FOR HEMOPHILIA A
  • STORAGE OF DRIED BLOOD SPOTS: GENETIC, HEALTH SERVICE AND RESEARCH POLICY IMPLICATIONS
  • SUBVENTION DE FORMATION DES IRSC-FRSQ EN MÉDECINE GÉNÉTIQUE APLIQUÉE
  • SUSCEPTIBILITÉ GÉNÉTIQUE AU CANCER DU SEIN: ÉCHANGE INTERNATIONAL DE DONNÉES ET DISCRIMINATION GÉNÉTIQUE
  • TECHNIQUES OF INVESTIGATION AND PARAMETERS DEVELOPMENT FOR THE STUDY OF ETHICAL AND SOCIAL ISSUES OF GENETIC SCREENING FOR A MULTICULTURAL COMMUNITY: SICKLE-CELL DISEASE PILOT PROJECT
  • THE CANADIAN ALLIANCE FOR HEALTHY HEARTS AND MINDS
  • THE CARTOGRAPHY OF INTESTINAL MICROBIAL COMMUNITIES IN A NHP MODEL SYSTEM
  • THE FUTURE OF CORD BLOOD BANKING IN CANADA
  • THE GRID (GENES, REGULATORS IN DISEASES) PROJECT
  • THE IMPACTS OF THE LACK OF LEGAL RECOGNITION OF GENETIC COUNSELORS IN QUEBEC
  • THE INTERNATIONAL CANCER GENOME CONSORTIUM (ICGC) DATA ACCESS COMPLIANCE OFFICE (DACO)
  • THE LEUCEGENE PROJECT: TRANSCRIPTOME SEQUENCING TO IDENTIFY NOVEL PROGNOSTIC MARKERS AND THERAPEUTIC TARGETS IN ACUTE MYELOID LEUKEMIA
  • THE NORMATIVE FRAMEWORK GOVERNING INFECTIOUS AND/OR REPORTABLE DISEASES IN SELECTED JURISDICTIONS: INTERNATIONAL COMPARATIVE COMPENDIUM
  • THE QUÉBEC NETWORK OF APPLIED GENETIC MEDICINE
  • THE STEM CELL RESEARCH ENVIRONMENT: DRAWING THE EVIDENCE AND EXPERIENCE TOGETHER
  • THE TERRY FOX NEW FRONTIERS PROGRAM PROJECT IN GENOMIC DETERMINANTS OF CHILDHOOD
  • THE TERRY FOX NEW FRONTIERS PROGRAM PROJECT IN GENOMIC DETERMINANTS OF CHILDHOOD LEUKEMIA
  • THÉCELL (RÉSEAU DE THÉRAPIE CELLULAIRE ET TISSULAIRE)
  • THÉCELL (RÉSEAU DE THÉRAPIE CELLULAIRE ET TISSULAIRE) : ENJEUX SOCIO-ÉTHIQUES ET JURIDIQUES DES THÉRAPIES CELLULAIRES ET TISSULAIRES
  • THÉCELL (RÉSEAU DE THÉRAPIE CELLULAIRE ET TISSULAIRE) RECHERCHE SUR LES MALADIES RARES: VIE PRIVÉE «BON GRÉ MAL GRÉ»?
  • TOWARDS A COMMON LANGUAGE FOR BIOBANKING?
  • TOWARDS SYSTEMS MEDICINE FOR FATTY LIVER DISEASE
  • TOWARDS THE CLINIC?: ETHICAL, LEGAL AND SOCIAL ISSUES (ELSI) RELEVANT TO EMERGING STEM CELL THERAPIES
  • TRANSLATING GENETICS DISCOVERIES INTO APPROPRIATE HEALTH POLICY AND SERVICES
  • TRANSLATION CHALLENGES, SCIENCE POLICY AND STEM CELL RESEARCH
  • TREATMENT OF PATIENTS WITH CORNEAL LIMBAL STEM CELL DEFICIENCIES USING CULTURED EPITHELIAL CORNEAL AUTORAFTS
  • Current Projects
    Privacy Policy for our studies using Facebook
    Funders